Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Global Cardiovascular Risk Assessment in Different Clinical Settings

Basal Results of the EFFECTUS (Evaluation of Final Feasible Effect of Control Training and Ultra-Sensitisation) Programme

Abstract

Background: Cardiovascular diseases still represent the leading cause of morbidity and mortality, worldwide. Early detection and appropriate management of major cardiovascular risk factors in clinical practice may improve preventive strategies in Western countries, including Italy.

Objective: To evaluate the prevalence of major cardiovascular risk factors and their impact on routine clinical practice of Italian general practitioners (GPs), cardiologists and diabetologists.

Methods: The study involved physicians who participated in an educational project on cardiovascular risk management, the EFFECTUS (Evaluation of Final Feasible Effect of Control Training and Ultra-Sensitisation) programme. Physicians were asked to report data already available in their clinical records of the first ten consecutive adult outpatients during May 2006. Data collection included patients’ full medical history and therapies, physical examination (anthropometric parameters and blood pressure levels), laboratory results and diagnostic examinations. Data were then centrally analysed for global cardiovascular risk evaluation and cardiovascular risk profile characterization. The present study provides data from the baseline records of the EFFECTUS programme.

Results: A total of 1078 physicians (73% males and 27% females, mean age 50 ± 7 years), of which 841 (78%) were GPs, 140 (13%) cardiologists and 97 (9%) diabetologists, included data from 9904 outpatients (5300 males and 4604 females, mean age 67 ± 9 years). In the overall population, 2504 (25%) subjects were obese, 7436 (75%) had hypertension, 5873 (59%) had dyslipidaemia, 3681 (37%) had diabetes mellitus and 2633 (27%) had a history of ischaemic heart disease, while 1102 (11%) and 1247 (13%) had cerebral or peripheral artery disease, respectively. Significant differences were reported in the prevalence of detected cardiovascular risk factors among physicians operating in different clinical settings. Moreover, different clinical habits were recorded.

Conclusions: The present analysis illustrates a very high prevalence of cardiovascular risk factors, irrespective of the clinical settings in which patients were followed, in a vast Italian population. The study also describes differences in management of cardiovascular risk factors among physicians operating in different clinical settings.

This is a preview of subscription content, log in to check access.

Table I
Table II
Fig. 1
Table III
Table IV
Table V
Table VI

References

  1. 1.

    Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004 Sep 11–17; 364(9438): 953–62

  2. 2.

    Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 Sep 11–17; 364(9438): 937–52

  3. 3.

    Mendis S, Lindholm LH, Mancia G, et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens 2007 Aug; 25(8): 1578–82

  4. 4.

    Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007 Sep; 14Suppl. 2: S1–113

  5. 5.

    Kindermann M, Adam O, Werner N, et al. Clinical Trial Updates and Hotline Sessions presented at the European Society of Cardiology Congress 2007: (FINESSE, CARESS, OASIS 5, PRAGUE-8, OPTIMIST, GRACE, STEEPLE, SCAAR, STRATEGY, DANAMI-2, ExTRACT-TIMI-25, ISAR-REACT 2, ACUITY, ALOFT, 3CPO, PROSPECT, EVEREST, COACH, BENEFiT, MERLIN-TIMI 36, SEARCH-MI, ADVANCE, WENBIT, EUROASPIRE I-III, ARISE, getABI, RIO). Clin Res Cardiol 2007 Nov; 96(11): 767–86

  6. 6.

    Volpe M, Tocci G, Trimarco B, et al. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007 Jul; 25(7): 1491–8

  7. 7.

    Volpe M, Machado E. Treatment priorities and current prescribing patterns in hypertension: results of GRASP, an international physician survey. Curr Med Res Opin 2004 Jul; 20(7): 1151–60

  8. 8.

    Volpe M, Tocci G. Managing hypertension in cardiology practice according to risk profile. Int J Clin Pract 2008 Sep; 62(9): 1403–12

  9. 9.

    Tocci G, Giovannelli F, Sciarretta S, et al. Management of hypertension and stroke prevention: results of the Italian cardiologist survey. Int J Clin Pract 2009 Feb; 63(2): 207–16

  10. 10.

    Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007 Jun; 25(6): 1105–87

Download references

Acknowledgements

The authors wish to thank the 1078 Italian physicians for their contribution to this project. This work has been supported by an unconditional educational grant by Merck Sharp & Dohme, Italy. The present study was endorsed by the Italian Society of Cardiovascular Prevention (SIPREC). The authors have been supported by a grant funding from Merck Sharp & Dohme, Italy.

Author information

Correspondence to Prof. Massimo Volpe.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Volpe, M., Tocci, G., Avogaro, A. et al. Global Cardiovascular Risk Assessment in Different Clinical Settings. High Blood Press Cardiovasc Prev 16, 55–63 (2009). https://doi.org/10.2165/00151642-200916020-00004

Download citation

Key words

  • global cardiovascular risk
  • risk factors
  • hypertension
  • hypercholesterolaemia
  • general practice
  • cardiovascular risk management
  • cardiovascular prevention